MAZE THERAPEUTICS, INC. (MAZE) ROA
- 2026-06-30: ROA -25.13%.
- 2026-03-31: ROA -29.20%.
- 2025-12-31: ROA -33.02%.
- 2025-09-30: ROA -29.88%.
Complete source-backed roa history.
- Available history
- 2024-12-31 to 2026-06-30
- Data captured
Historical ROA
| Date | ROA |
|---|---|
| 2026-06-30 | -25.13% |
| 2026-03-31 | -29.20% |
| 2025-12-31 | -33.02% |
| 2025-09-30 | -29.88% |
| 2025-06-30 | -39.80% |
| 2025-03-31 | 15.60% |
| 2024-12-31 | 21.71% |
Annual ROA
| Date | ROA |
|---|---|
| 2025-12-31 | -33.02% |
| 2024-12-31 | 21.71% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |